@inproceedings{inproceedings, title  = {{Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2)}},

 url = {{}},

 year = {{2017}},

 month = {{4}},

 author = {{Simpson EL and Bieber T and Guttman-Yassky E and Beck LA and Blauvelt A and Cork MJ and Silverberg JI and Deleuran M and Kataoka Y and Lacour J-P and Kingo K et al}},

 volume = {{15}},

 journal = {{JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT}},

 pages = {{79-79}},

 note = {{Accessed on 2024/12/22}}}